Get started
Author

Judith C. van Deutekom

Observed names: J C van Deutekom, J. C. v. Deutekom, J. C. van Deutekom, J.C. van Deutekom, Judith C. Van Deutekom, Judith CT van Deutekom
OpenAlex ID: A5113782001
Local Dystrophin Restoration with Antisense Oligonucleotide PRO051
2007 · Judith C. van Deutekom, Anneke A. Janson, et al. · New England Journal of Medicine · 781
Systemic Administration of PRO051 in Duchenne's Muscular Dystrophy
2011 · Nathalie M. Goemans, Mar Tulinius, et al. · New England Journal of Medicine · 678
PDF
Comparative Analysis of Antisense Oligonucleotide Sequences for Targeted Skipping of Exon 51 During Dystrophin Pre-mRNA Splicing in Human Muscle
2007 · V. Arechavala-Gomeza, I.R. Graham, et al. · Human Gene Therapy · 153
PDF
Preclinical PK and PD Studies on 2′-O-Methyl-phosphorothioate RNA Antisense Oligonucleotides in the mdx Mouse Model
2010 · Hans Heemskerk, Christa de Winter, et al. · Molecular Therapy · 141
PDF
Dystrophin levels and clinical severity in Becker muscular dystrophy patients
2013 · J. C. van den Bergen, B. H. Wokke, et al. · Journal of Neurology Neurosurgery & Psychiatry · 128
Use of capillary Western immunoassay (Wes) for quantification of dystrophin levels in skeletal muscle of healthy controls and individuals with Becker and Duchenne muscular dystrophy
2018 · Chantal Beekman, Anneke A. Janson, et al. · PLoS ONE · 126
PDF
Long-Term Efficacy, Safety, and Pharmacokinetics of Drisapersen in Duchenne Muscular Dystrophy: Results from an Open-Label Extension Study
2016 · Nathalie M. Goemans, Már Tulinius, et al. · PLoS ONE · 96
PDF
Dystrophin nonsense mutation induces different levels of exon 29 skipping and leads to variable phenotypes within one BMD family
2000 · Ieke B Ginjaar, Alexander LJ Kneppers, et al. · European Journal of Human Genetics · 92
Design and Analysis of Effects of Triplet Repeat Oligonucleotides in Cell Models for Myotonic Dystrophy
2013 · Anchel González-Barriga, Susan AM Mulders, et al. · Molecular Therapy — Nucleic Acids · 48
PDF
A Sensitive, Reproducible and Objective Immunofluorescence Analysis Method of Dystrophin in Individual Fibers in Samples from Patients with Duchenne Muscular Dystrophy
2014 · Chantal Beekman, Jessica A. Sipkens, et al. · PLoS ONE · 42
PDF
Low dystrophin variability between muscles and stable expression over time in Becker muscular dystrophy using capillary Western immunoassay
2021 · Z. Koeks, A. A. Janson, et al. · Scientific Reports · 24
PDF
Mutation in DHP receptor alpha 1 subunit (CACLN1A3) gene in a Dutch family with hypokalaemic periodic paralysis.
1995 · R H Boerman, R A Ophoff, et al. · Journal of Medical Genetics · 24
PDF
Using a State-of-the-Art Toolbox to Evaluate Molecular and Functional Readouts of Antisense Oligonucleotide-Induced Exon Skipping in mdx Mice
2019 · Nicole A. Datson, Suzanne Bijl, et al. · Nucleic Acid Therapeutics · 10
PDF
Antisense oligonucleotides as personalized medicine for Duchenne muscular dystrophy
2013 · Judith C. van Deutekom, Sjef J. de Kimpe, et al. · Drug Discovery Today Therapeutic Strategies · 9
Exon skipping for DMD
2012 · Annemieke Aartsma-Rus, Jan JGM Verschuuren, et al. · Orphanet Journal of Rare Diseases · 3
PDF
Correction: Use of capillary Western immunoassay (Wes) for quantification of dystrophin levels in skeletal muscle of healthy controls and individuals with Becker and Duchenne muscular dystrophy
2025 · Chantal Beekman, Anneke A. Janson, et al. · PLoS ONE
PDF
L2 The expanded cag repeat in the huntingtin gene as target for therapeutic RNA modulation throughout the R6/2 and Q175 HD mouse brain
2016 · Anchel González-Barriga, Eleni Kourkouta, et al. · Journal of Neurology Neurosurgery & Psychiatry
Works count: 18
Citation count: 2,355
H-index: 12
I10-index: 13
Year
Topic
Type